A first-in-man clinical trial of IMT-07 for solid tumors
Latest Information Update: 22 Jul 2022
At a glance
- Drugs IMT-07 (Primary)
- Indications Solid tumours
- Focus Adverse reactions; First in man
- 20 Jul 2022 According to a iOmx Therapeutics media release, this trial is planned to start at end of this year.
- 07 Oct 2021 New trial record
- 05 Oct 2021 According to a MIG Capital AG media release, the trial is planned to start in late 2022